These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24813570)

  • 1. Gender and injuries predict stimulant medication use.
    Dalsgaard S; Leckman JF; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):253-9. PubMed ID: 24813570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
    Dalsgaard S; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands.
    Faber A; Kalverdijk LJ; de Jong-van den Berg LT; Hugtenburg JG; Minderaa RB; Tobi H
    Eur Child Adolesc Psychiatry; 2010 Feb; 19(2):159-66. PubMed ID: 19894075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
    Garbe E; Mikolajczyk RT; Banaschewski T; Petermann U; Petermann F; Kraut AA; Langner I
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):452-8. PubMed ID: 23234588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Age, Gender, and Living Circumstances on Patterns of Attention-Deficit/Hyperactivity Disorder Medication Use in Children and Adolescents With or Without Intellectual Disabilities.
    Osunsanmi S; Turk J
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):828-834. PubMed ID: 26982546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
    Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S; Kvist AP; Leckman JF; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):302-10. PubMed ID: 24956171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network.
    Hoang U; James AC; Liyanage H; Jones S; Joy M; Blair M; Rigby M; Lusignan S
    BMJ Evid Based Med; 2019 Aug; 24(4):155-161. PubMed ID: 30765384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
    Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac reactivity and stimulant use in adolescents with autism spectrum disorders with comorbid ADHD versus ADHD.
    Bink M; Popma A; Bongers IL; van Boxtel GJ; Denissen A; van Nieuwenhuizen Ch
    J Autism Dev Disord; 2015 Feb; 45(2):481-94. PubMed ID: 24005985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.